A counterweight to market volatility
With significant market power across the drug supply chain, pharmaceutical manufacturers have sole discretion over medication pricing. That’s why it’s so important that we serve as the counterweight — and we are. Through negotiations, we’re lowering prescription drug prices and improving health outcomes:
- For every $1 spent, pharmacy benefit managers (PBMs) reduce costs by $10.
- Over the next 10 years, PBMs will help prevent 1 billion medication errors.
- 9 in 10 employers are satisfied with their PBM.
- We pass through 98% of the negotiated discounts and pharmacy rates to clients.
Related healthcare insights
Article
New pills and expanded indications are poised to alter the dynamics of GLP-1 costs and treatments.
Article
We delivered a seamless 1/1 transition for over 800 new clients with strong service, stable operations and improved member experiences.
Article
The move to Maximum Fair Prices for popular drugs will trigger new economic considerations for plan sponsors.
Article
Two AI experts share insights on how we’re using AI and advanced technology to improve everything from trend prediction to member services.
Article
Rising pharmacy costs extend far beyond GLP-1s — inflammatory conditions and oncology therapies continue to drive significant spend.
Complementary solutions
Weight Engage
Get the most from these pricey new obesity drugs by choosing the right coverage strategy and helping your members build lifelong habits.
Pharmacy benefits backed by data and insight
We help members, providers and clients act with clarity and confidence — earlier and faster.
- 2025 analysis.
- KLAS Research, 2024.
- 2024 analysis.